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Recurrent vulvovaginal candidiasis- where does Candida
albicans persist?
F. Beikert ∗, M.T. Le, A. Clad
University of Freiburg, Freiburg, Germany
Background: 5-8% of all women of childbearing age suf-
fer from recurrent vulvovaginal candidiasis (RVVC). In most
cases, recurrences are caused by identical Candida strains
suggesting a site of C. albicans persistence in female geni-
talia. The purpose of this study was (1) to investigate where
C. albicans persists despite prolonged oral therapy, (2) to
determine the clinical symptoms and signs related to C.
albicans positive vulvar cultures and (3) to evaluate a new
therapeutic approach in women with positive interlabial cul-
tures.
Methods: A total of 469 women with recurrent vul-
vovaginal complaints were examined by colposcopy and
microscopy of vaginal smears was performed. Swabs were
obtained from both vagina and interlabial sulcus of the
external vulva and cultured for fungal growth. Women
with positive C. albicans cultures from the external vulva
received 100mg of oral ﬂuconazole daily for 20 days and top-
ical ciclopiroxolamin cream applied in the interlabial sulcus
and perianally for 4 weeks. Follow-up visits were at 3, 6, 9
and 12 months.
Results: Of 469 women with chronic vulvovaginal com-
plaints, 139 patients (30%) had positive C. albicans cultures.
Of these 139 patients, 70% had both C. albicans positive vul-
var and vaginal cultures, 24% had positive cultures from the
vagina only and 6% from the interlabial sulcus only. Pruri-
tus (OR 5.4; 95% CI 2.0 - 14.9), signs of vulvar edema (OR
3,8; 95%CI 1.0-16.8) and ﬁssures (OR 2.4; 95%CI 1.0-5.8)
correlated with positive vulvar cultures.
Recurrence rates for the combined treatment were 27%
at 6 months and 34% at 12 months.
Conclusion: Our results point at the stratum corneum of
the moist interlabial sulcus rather than the non-keratinizing
vaginal epithelium as the site of C. albicans persistence and
source of endogenous re-infection in patients with recur-
rent vulvovaginal candidiasis. Based on this hypothesis and
analogous with the treatment of nail mycosis, we used a
combination of the fungistatic ﬂuconazole and fungicidal
ciclopiroxolamin cream. This new approach showed promis-
ing results.
doi:10.1016/j.ijid.2010.02.1752
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Delayed diagnosis of disseminated Histoplasmosis cap-
sulatum var. capsulatum infection in AIDS patients in a
tuberculosis high endemic country
P. soentjens1,∗, I. Eshun-Wilson2, J. Taljaard3
1 Military Hospital Brussels, Brussels, Belgium
2 Tygerberg Academic Hospital, CapeTown, South Africa
3 Tygerberg academic Hospital, Cape Town, South Africa
Background: Histoplasmosis is an low endemic myco-
sis in some parts of South Africa. The ﬁnal diagnosis of
disseminated histoplasmosis (DH) requires pathology and
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icrobiology. Diagnosis and effective treatment is often
elayed in resource-constrained settings, because clinical
eatures could be confused with disseminated tuberculosis,
nd specialized services are limited. To our knowledge, this
s the ﬁrst reported case series of HIV infected patients with
H in Africa.
Methods: We report retrospective descriptive data on a
eries of HIV and DH co-infected patients attending an aca-
emic hospital between September 2003 and December 2008
n the Western Cape region.
Clinical and laboratory characteristics of all diagnosed
H were analysed with the statistical package SPSS 15.0.
Results: During the study period, 11 cases of DH were
iagnosed: the majority of cases occurred in men (82%).
All DH patients presented with skin lesions in addi-
ion to other symptoms of which 6 had fever (55%), 9
ad constitutional symptoms (weakness, night sweats and
eight loss) (82%), 6 had epistaxis (55%), 5 had respira-
ory symptoms (45%), and 4 had gastrointestinal complaints
36%).
The mean CD4 lymphocyte count was 43 cells/l (IQR:
-107). The mean CRP level was 166 mg/dl (IQR: 27-306),
he LDH was 887 U/l (IQR: 158-3220). Pancytopenia was
iagnosed in 3 patients.
Diagnosis was made in all patients by positive
istopathology results (100%); only 3 patients had a micro-
iologically conﬁrmed culture result (27%). The mean
ime-interval between ﬁrst symptoms and treatment was
48 days (IQR: 80-305).
Three patients developed paradoxical IRIS features
27%) and three patients unmasking DH after initiation of
ntiretroviral treatment (ART) (27%). One patient died of
H (9%), due to delayed diagnosis and treatment, after two
ays of intravenous amphotericin.
Conclusion: In a tuberculosis high endemic region, where
any AIDS patients with a very low CD4 count are seen in
ntiretroviral clinics, the follow-up of patients is complex,
ostly due to TB related infections.
A high index of suspicion for DH is necessary to detect
peciﬁc clinical characteristics on time. Patients who
resent with constitutional symptoms and skin lesions should
e checked for DH through pathology and/or microbiology. A
resenting epistaxis, and a relative high CRP should increase
he likelihood of the diagnosis of DH.
oi:10.1016/j.ijid.2010.02.1753
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reakthrough Rhizopus spp. in an immunocompromised
atient receiving caspofungin. Case Report and review
. Dunkel ∗, J. Ambrosioni, Y. Chalandon, J. Passweg, J.
arbino
University Hospital of Geneva, Geneva, Switzerland
Background: Invasive zygomycosis is a rare opportunis-
ic fungal disease, with high morbidity and mortality rates
hat affects predominantly immunosuppressed patients. An
ncrease incidence is observed with the widespread use of
ewer antifungal drugs, such as voriconazol and caspofun-
in. We report a case of breakthrough invasive zygomycosis
n a stem cell transplant recipient on sequential voricona-
